The above two studies show that angioimmunoblastic T-cell lymphoma and anaplastic large-cell lymphoma (anaplastic lymphoma kinase-negative) showed better response rates and durable responses than other subtypes [57]. This evidence concerns the gene ALK and angioimmunoblastic T-cell lymphoma.